Oncternal Therapeutics (NASDAQ:ONCT) Research Coverage Start

StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a report released on Saturday morning. The firm issued a sell rating on the stock. ONCT has been the topic of several other research reports. Cantor Fitzgerald cut Oncternal Therapeutics from an overweight rating to a neutral rating in a report on […]

Related Keywords

San Diego , California , United States , Davidf Hale , Jamesb Breitmeyer , , Oncternal Therapeutics Company Profile , Cantor Fitzgerald , Maxim Group , Healthcare Of Ontario Pension Plan Trust Fund , Oncternal Therapeutics Inc , Millennium Management , Securities Exchange Commission , Nasdaq , Vanguard Group Inc , Renaissance Technologies , Oncternal Therapeutics , Get Rating , Capital Acquisition , Brookline Capital Management , Exchange Commission , Ontario Pension Plan Trust Fund , Two Sigma Investments , Sigma Investments , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Initiated Coverage , Stocknews Com ,